Cargando…
Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study
OBJECTIVES: Describe and compare the risk of cardiovascular and non-cardiovascular mortality in patients whose antidiabetic therapy is modified to include pioglitazone compared with an alternative antidiabetic medication at the same stage of disease progression. RESEARCH DESIGN AND METHODS: This exp...
Autores principales: | Strongman, Helen, Christopher, Solomon, Majak, Maila, Williams, Rachael, Bahmanyar, Shahram, Linder, Marie, Heintjes, Edith M, Bennett, Dimitri, Korhonen, Pasi, Hoti, Fabian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783110/ https://www.ncbi.nlm.nih.gov/pubmed/29379607 http://dx.doi.org/10.1136/bmjdrc-2017-000481 |
Ejemplares similares
-
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study
por: Strongman, Helen, et al.
Publicado: (2017) -
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
por: Korhonen, Pasi, et al.
Publicado: (2016) -
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
por: Buse, John B., et al.
Publicado: (2020) -
Noninvasive Evaluation of Neural Impairment in Subjects With Impaired Glucose Tolerance
por: Putz, Zsuzsanna, et al.
Publicado: (2009) -
Disparities in cardiometabolic risk profiles and gestational diabetes mellitus by nativity and acculturation: findings from 2016–2017 National Health Interview Survey
por: Ogunwole, S Michelle, et al.
Publicado: (2022)